Insulin resistance in patients with chronic kidney disease

被引:190
|
作者
Kobayashi, S
Maesato, K
Moriya, H
Ohtake, T
Ikeda, T
机构
[1] Shonan Kamakura Gen Hosp, Dept Nephrol, Kamakura, Kanagawa 2478533, Japan
[2] Shonan Kamakura Gen Hosp, Kidney & Dialysis Ctr, Kamakura, Kanagawa 2478533, Japan
[3] Jinguumae Clin, Tokyo, Japan
关键词
insulin resistance; chronic kidney disease (CKD); acidosis; apolipoprotein (Apo) A-1/B; fibrinogen;
D O I
10.1053/j.ajkd.2004.09.034
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: It has been reported that insulin resistance appears at an earlier stage of chronic kidney disease (CKD). However, few data are available concerning what factors of metabolic abnormalities, such as apolipoprotein (Apo) profile or acidosis, might be associated with insulin resistance in patients with CKD. Methods: We used the hyperinsulinemic euglycemic glucose clamp technique to examine insulin sensitivity in patients without diabetes (n = 29) with different stages of renal function. Results were compared with those in healthy subjects (n = 10) and related to various affecting variables. Results: In healthy subjects, the glucose disposal rate (GDR) was 9.93 +/- 1.33 mg/kg/min. The GDR of patients with CKD (6.91 +/- 2.46 mg/kg/min) was significantly less than that of healthy subjects (P < 0.01), which shows diminished insulin sensitivity in patients with CKD. There was a negative correlation between GDR and serum creatinine level (r = -0.449; P < 0.05) and positive correlations between GDR and creatinine clearance (r = 0.549; P < 0.01) and Apo A-1/B levels (r = 0.396; P < 0.05). Of particular relevance is the observed close correlation between GDR and bicarbonate level, with an extremely high predictive value for degree of acidosis (r = 0.611; P < 0.0005). Stepwise multivariate regression analysis selected bicarbonate (F = 13.28) and Apo A-1/B levels (F = 6.58) as independent contributing variables. Conclusion: We found that insulin resistance correlated linearly with decline in renal function. Independent variables related to insulin resistance were bicarbonate and Apo A-1/B levels in patients with CKD.
引用
收藏
页码:275 / 280
页数:6
相关论文
共 50 条
  • [21] Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans
    Hosoya, Kozi
    Minakuchi, Hitoshi
    Wakino, Shu
    Fujimura, Keiko
    Hasegawa, Kazuhiro
    Komatsu, Motoaki
    Yoshifuji, Ayumi
    Futatsugi, Koji
    Shinozuka, Keisuke
    Washida, Naoki
    Kanda, Takeshi
    Tokuyama, Hirobumi
    Hayashi, Koichi
    Itoh, Hiroshi
    KIDNEY INTERNATIONAL, 2015, 87 (04) : 749 - 760
  • [22] Insulin Resistance and Vitamin D Deficiency in Patients With Chronic Kidney Disease Stage 2-3
    Stefikova, K.
    Spustova, V.
    Krivosikova, Z.
    Oksa, A.
    Gazdikova, K.
    Fedelesova, V.
    Dzurik, R.
    PHYSIOLOGICAL RESEARCH, 2011, 60 (01) : 149 - 155
  • [23] Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease
    J. David Smeijer
    Donald E. Kohan
    Peter Rossing
    Ricardo Correa-Rotter
    Adrian Liew
    Sydney C.W. Tang
    Dick de Zeeuw
    Ron T. Gansevoort
    Wenjun Ju
    Hiddo J. Lambers Heerspink
    Cardiovascular Diabetology, 22
  • [24] Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease
    Smeijer, J. David
    Kohan, Donald E.
    Rossing, Peter
    Correa-Rotter, Ricardo
    Liew, Adrian
    Tang, Sydney C. W.
    de Zeeuw, Dick
    Gansevoort, Ron T.
    Ju, Wenjun
    Heerspink, Hiddo J. Lambers
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [25] Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field
    Natasha Dave
    Jiao Wu
    Sandhya Thomas
    Current Diabetes Reports, 2018, 18
  • [26] Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field
    Dave, Natasha
    Wu, Jiao
    Thomas, Sandhya
    CURRENT DIABETES REPORTS, 2018, 18 (07)
  • [27] Retention of acetylcarnitine in chronic kidney disease causes insulin resistance in skeletal muscle
    Miyamoto, Yasunori
    Miyazaki, Teruo
    Honda, Akira
    Shimohata, Homare
    Hirayama, Kouichi
    Kobayashi, Masaki
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2016, 59 (03) : 199 - 206
  • [28] Insulin resistance in chronic kidney disease: its clinical characteristics and prognostic significance
    Caravaca, F.
    Cerezo, I.
    Macias, R.
    Garcia de Vinuesa, E.
    Martinez del Viejo, C.
    Villa, J.
    Martinez Gallardo, R.
    Ferreira, F.
    Hernandez-Gallego, R.
    NEFROLOGIA, 2010, 30 (06): : 661 - 668
  • [29] Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventions
    Chan, Doris T.
    Watts, Gerald F.
    Irish, Ashley B.
    Dogra, Gursharan K.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (08) : 1274 - 1281
  • [30] Insulin resistance and inflammation in chronic kidney diseases
    Guebre-Egziabher, Fitsum
    Kalbacher, Emilie
    Fouque, Denis
    NEPHROLOGIE & THERAPEUTIQUE, 2009, 5 : S346 - S352